References
- Tefferi A. Myelofibrosis with myeloid metaplasia. N Engl J Med 2000;342:1255–1265.
- Pennucci V, Zini R, Norfo R, et al. Abnormal expression patterns of WT1-as, MEG3 and ANRIL long non-coding RNAs in CD34 + cells from patients with primary myelofibrosis and their clinical correlations. Leuk Lymphoma 2015;56:492–496.
- Dallosso AR, Hancock AL, Malik S, et al. Alternately spliced WT1 antisense transcripts interact with WT1 sense RNA and show epigenetic and splicing defects in cancer. RNA 2007;13: 2287–2299.
- Sugiyama H. WT1 (Wilms’ tumor gene 1): biology and cancer immunotherapy. Jpn J Clin Oncol 2010;40:377–387.
- Garitano-Trojaola A, Agirre X, Prosper F, et al. Long non-coding RNAs in haematological malignancies. Int J Mol Sci 2013;14: 15386–15422.
- Barosi G, Viarengo G, Pecci A, et al. Diagnostic and clinical relevance of the number of circulating CD34(+) cells in myelofibrosis with myeloid metaplasia. Blood 2001;98:3249–3255.
- Guo Y, Lubbert M, Engelhardt M. CD34- hematopoietic stem cells: current concepts and controversies. Stem Cells 2003;21: 15–20.
- Nguyen LH, Dueans V, Chen MY, et al. Progenitor cells: role and usage in bone tissue engineering approaches for spinal fusion. In: Jandial R, Chen MY, editors. Regenerative biology of the spine and spinal cord. New York: Springer; 2012. ch 12.
- Eades G, Zhang YS, Li QL, et al. Long non-coding RNAs in stem cells and cancer. World J Clin Oncol 2014;5:134–141.